Author： Norman Peter
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.5, 2002-05, pp. : 725-732
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pfizer: analysis of patenting 1995 - 1998
By Adams S.
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 11, 1998-11 ,pp. :
Access to resources
Recommend
Merck & Co., Inc.: analysis of patenting 1998 – 2002
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 7, 2003-07 ,pp. :
GlaxoSmithKline plc: analysis of patenting 1998 – 2001
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 9, 2002-09 ,pp. :
Pharmacia Corp.: analysis of patenting 1998 – 2002
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2002-02 ,pp. :
SmithKline Beecham: analysis of patenting 1995 - 1998
By Adams S.
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 9, 1999-09 ,pp. :